Terms: = Liver cancer AND CACNA1D, CCHL1A2, Cav1_3, CACNL1A2, CACN4, CACH3, ENSG00000157388, 776
146 results:
1. [Construction and Validation of Prediction Models of Risk Factors for Early Death in Patients With Metastatic Melanoma].
Li S; Li J; Yang Q; Yin C; Liu B
Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 Mar; 55(2):367-374. PubMed ID: 38645854
[TBL] [Abstract] [Full Text] [Related]
2. Tumor conspicuity enhancement-based segmentation model for liver tumor segmentation and RECIST diameter measurement in non-contrast CT images.
Liu H; Zhou Y; Gou S; Luo Z
Comput Biol Med; 2024 May; 174():108420. PubMed ID: 38613896
[TBL] [Abstract] [Full Text] [Related]
3. A gadoxetic acid-enhanced MRI-based model using LI-RADS v2018 features for preoperatively predicting Ki-67 expression in hepatocellular carcinoma.
Liang Y; Xu F; Mou Q; Wang Z; Xiao C; Zhou T; Zhang N; Yang J; Wu H
BMC Med Imaging; 2024 Jan; 24(1):27. PubMed ID: 38273242
[TBL] [Abstract] [Full Text] [Related]
4. Predicting 5-year recurrence risk in colorectal cancer: development and validation of a histology-based deep learning approach.
Xiao H; Weng Z; Sun K; Shen J; Lin J; Chen S; Li B; Shi Y; Kuang M; Song X; Weng W; Peng S
Br J Cancer; 2024 Apr; 130(6):951-960. PubMed ID: 38245662
[TBL] [Abstract] [Full Text] [Related]
5. Comparative effectiveness of warfarin in cirrhotic patients with non-symptomatic portal vein thrombosis: a multicenter, randomized controlled trial.
Lu S; Chen J; Zhang R; Luo T; Ma L; Xu P; Ding H; Zeng X; Wu B; Shi Y; Liu C; Mu Y; Chen S; Wang J
Expert Rev Gastroenterol Hepatol; 2024; 18(1-3):5-12. PubMed ID: 38236640
[TBL] [Abstract] [Full Text] [Related]
6. Protein-centric omics analysis reveals circulating complements linked to non-viral liver diseases as potential therapeutic targets.
Shi Y; Dong H; Sun S; Wu X; Fang J; Zhao J; Han J; Li Z; Wu H; Liu L; Wu W; Tian Y; Yuan G; Fan X; Xu C
Clin Mol Hepatol; 2024 Jan; 30(1):80-97. PubMed ID: 38061333
[TBL] [Abstract] [Full Text] [Related]
7. Role of miR
Cao Z; Zeng L; Wang Z; Zhou Y; Qian K
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Sept 28; 48(9):1281-1295. PubMed ID: 38044639
[TBL] [Abstract] [Full Text] [Related]
8. The decreased risk of hepatocellular carcinoma in hepatitis B virus-related cirrhotic portal hypertension patients after laparoscopic splenectomy and azygoportal disconnection.
Gao TM; Xiao KQ; Xiang XX; Jin SJ; Qian JJ; Zhang C; Zhou BH; Tang H; Bai DS; Jiang GQ
Surg Endosc; 2023 Nov; 37(11):8522-8531. PubMed ID: 37775601
[TBL] [Abstract] [Full Text] [Related]
9. Prediction of prognosis of patients with hepatocellular carcinoma based on immune-related score.
Song XQ; Li RJ; Zhang S
Asian J Surg; 2024 Jan; 47(1):310-319. PubMed ID: 37673742
[TBL] [Abstract] [Full Text] [Related]
10. [The clinical value of serum GPC3 level in predicting recurrence of patients with primary hepatocellular carcinoma].
Zhang PR; Ma XL; Guo L; Lu RQ
Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Jun; 57(6):885-890. PubMed ID: 37357208
[No Abstract] [Full Text] [Related]
11. [Evaluation of clinical safety and diagnostic efficacy of domestic liver-specific magnetic resonance contrast agent (gadoxetate disodium)].
Yang T; Ye Z; Yao S; Li Y; Song B
Zhonghua Gan Zang Bing Za Zhi; 2023 Feb; 31(2):161-167. PubMed ID: 37137831
[No Abstract] [Full Text] [Related]
12. Prediction of Hepatocellular Carcinoma Development in Korean Patients after Hepatitis C Cure with Direct-Acting Antivirals.
Hong H; Choi WM; Lee D; Shim JH; Kim KM; Lim YS; Lee HC; Choi J
Gut Liver; 2024 Jan; 18(1):147-155. PubMed ID: 37076993
[TBL] [Abstract] [Full Text] [Related]
13. The systemic immune-inflammation index was non-linear associated with all-cause mortality in individuals with nonalcoholic fatty liver disease.
Zhao E; Cheng Y; Yu C; Li H; Fan X
Ann Med; 2023 Dec; 55(1):2197652. PubMed ID: 37052341
[TBL] [Abstract] [Full Text] [Related]
14. Incidence, survival comparison, and novel prognostic evaluation approaches for stage iii-iv pulmonary large cell neuroendocrine carcinoma and small cell lung cancer.
Huang L; Feng Y; Xie T; Zhu H; Tang L; Shi Y
BMC Cancer; 2023 Apr; 23(1):312. PubMed ID: 37020179
[TBL] [Abstract] [Full Text] [Related]
15. Association of oral lichen planus with hepatic disorders and hepatocellular carcinoma: systematic review and meta-analysis.
González-Moles MÁ; de Porras-Carrique T; Ramos-García P
Med Oral Patol Oral Cir Bucal; 2023 May; 28(3):e229-e237. PubMed ID: 36806023
[TBL] [Abstract] [Full Text] [Related]
16. Long noncoding RNA MyD88 functions as a promising diagnostic biomarker in hepatocellular carcinoma.
Wang Z; Gao P; Sun W; Rehman AU; Jiang J; Xu S; Xue C; Zhu C; Qin X
Front Endocrinol (Lausanne); 2023; 14():938102. PubMed ID: 36793272
[TBL] [Abstract] [Full Text] [Related]
17. Diagnostic Performance of Contrast Enhanced CT Alone or in Combination with (Non-)Enhanced MRI for Colorectal liver Metastasis.
Qiu QS; Zhu K; Wang JH; Chen XS; Wang WT; Dong SY; Sun W; Rao SX
Acad Radiol; 2023 Sep; 30(9):1856-1865. PubMed ID: 36481127
[TBL] [Abstract] [Full Text] [Related]
18. Long-term Outcomes of Endoscopic Intraductal Radiofrequency Ablation for Ampullary Adenoma with Intraductal Extension after Endoscopic Snare Papillectomy.
Cho SH; Oh D; Song TJ; Park DH; Seo DW; Lee SK; Kim MH; Lee SS
Gut Liver; 2023 Jul; 17(4):638-646. PubMed ID: 36472069
[TBL] [Abstract] [Full Text] [Related]
19. Clinical-radiomics predictors to identify the suitability of transarterial chemoembolization treatment in intermediate-stage hepatocellular carcinoma: A multicenter study.
Wang DD; Zhang JF; Zhang LH; Niu M; Jiang HJ; Jia FC; Feng ST
Hepatobiliary Pancreat Dis Int; 2023 Dec; 22(6):594-604. PubMed ID: 36456428
[TBL] [Abstract] [Full Text] [Related]
20. Integrative analysis of the characteristic of lipid metabolism-related genes for the prognostic prediction of hepatocellular carcinoma.
Zhu P; Zhang F; Deng W; Chen W
Medicine (Baltimore); 2022 Sep; 101(39):e30695. PubMed ID: 36181094
[TBL] [Abstract] [Full Text] [Related]
[Next]
